CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 85.24% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money

Trade PROCEPT BioRobotics Corp - PRCT CFD

57.00
0.14%
Market Trading Hours* (UTC) Open now
Closes on Wednesday at 20:00

Mon - Fri: 13:30 - 20:00

  • Summary
  • Historical Data
Trading сonditions
Spread 0.18
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.023679 %
Charges from full value of position ($-4.50)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.023679%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.001457 %
Charges from full value of position ($0.28)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.001457%
Overnight fee time 21:00 (UTC)
Min traded quantity 0.1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 57.01
Open 55.52
1-Year Change 18.3%
Day's Range 55.52 - 58.14
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Apr 1, 2025 57.01 -0.57 -0.99% 57.58 58.69 56.45
Mar 31, 2025 58.20 -0.25 -0.43% 58.45 58.74 55.10
Mar 28, 2025 60.00 -1.05 -1.72% 61.05 61.05 57.99
Mar 27, 2025 61.66 -0.29 -0.47% 61.95 62.48 60.55
Mar 26, 2025 62.28 0.32 0.52% 61.96 62.96 60.95
Mar 25, 2025 62.44 2.44 4.07% 60.00 64.15 59.48
Mar 24, 2025 60.85 2.35 4.02% 58.50 61.10 58.15
Mar 21, 2025 58.05 1.10 1.93% 56.95 58.44 55.95
Mar 20, 2025 57.81 0.60 1.05% 57.21 58.15 56.95
Mar 19, 2025 57.75 0.75 1.32% 57.00 58.17 56.09
Mar 18, 2025 56.94 -1.52 -2.60% 58.46 58.46 56.30
Mar 17, 2025 58.98 1.96 3.44% 57.02 59.18 57.01
Mar 14, 2025 57.53 1.58 2.82% 55.95 58.90 55.95
Mar 13, 2025 55.98 -0.98 -1.72% 56.96 57.45 54.95
Mar 12, 2025 57.55 -2.94 -4.86% 60.49 61.31 56.92
Mar 11, 2025 59.44 3.25 5.78% 56.19 60.58 56.19
Mar 10, 2025 57.46 -1.02 -1.74% 58.48 58.70 55.64
Mar 7, 2025 59.22 -0.73 -1.22% 59.95 60.85 58.23
Mar 6, 2025 60.44 -1.52 -2.45% 61.96 62.76 59.41
Mar 5, 2025 63.29 -2.02 -3.09% 65.31 65.31 61.22

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

PROCEPT BioRobotics Corporation Company profile

About Procept Biorobotics Corp

Procept Biorobotics Corporation is a commercial-stage surgical robotics company. The Company is focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia (BPH). Its AquaBeam Robotic System employs a single-use disposable handpiece to deliver its Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. It designs Aquablation therapy to deliver outcomes for males suffering from lower urinary tract symptoms (LUTS), due to BPH that are independent of prostate size and shape or surgeon experience.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Procept Biorobotics Corp revenues increased from $7.7M to $34.5M. Net loss increased 13% to $59.9M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Interest expense increase of 10% to $5.8M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -$1.25 to -$1.38.

Industry: Medical Equipment, Supplies & Distribution (NEC)

900 Island Drive
Suite 210
REDWOOD CITY
CALIFORNIA 94065
US

People also watch

BTC/USD

86,437.45 Price
+1.450% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 50.00

ETH/USD

1,886.09 Price
-1.280% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 1.75

Gold

3,123.36 Price
+0.310% 1D Chg, %
Long position overnight fee -0.0161%
Short position overnight fee 0.0079%
Overnight fee time 21:00 (UTC)
Spread 0.30

XRP/USD

2.14 Price
-0.160% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 0.01066

Still looking for a broker you can trust?

Join the 710,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading